-1.49% percent quarterly performance for X4 Pharmaceuticals Inc (XFOR) is not indicative of the underlying story
On Tuesday, X4 Pharmaceuticals Inc (NASDAQ: XFOR) was -3.61% drop from the session before settling in for the closing price of $0.51. A 52-week range